Skip to main content
logo
Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
58.65
-0.15 (-0.26%)
Sep 11, 2026, 4:00 PM EDT - Market closed

Xenon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5,6803,4632,9893,5032,4661,643
Market Cap Growth
98.49%15.89%-14.68%42.03%50.06%196.62%
Enterprise Value
4,4412,9172,1952,8751,7211,397
Last Close Price
58.6544.8239.2046.0639.4331.24

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-21.6521.6521.6521.6521.65
PS Ratio
-461.80--261.4189.14
PB Ratio
4.575.953.963.783.422.99
P/TBV Ratio
4.575.953.963.783.422.99
PEG Ratio
-2.512.512.512.512.51

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-388.87--182.4475.77

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.010.010.010.010.02
Net Debt / Equity Ratio
-1.00-0.99-0.99-0.99-0.98-0.99
Net Debt / EBITDA Ratio
2.821.562.694.345.566.96
Net Debt / FCF Ratio
3.662.074.045.876.847.60
Asset Turnover
-0.01--0.010.05
Quick Ratio
20.7113.1717.6623.4326.1238.72
Current Ratio
21.0213.4217.8523.6526.4439.03
Return on Equity (ROE)
-43.61%-51.76%-27.85%-22.12%-19.72%-21.87%
Return on Assets (ROA)
-28.02%-32.58%-19.80%-15.57%-12.17%-12.97%
Return on Capital Employed (ROCE)
-35.30%-63.10%-36.60%-22.80%-17.70%-14.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.20%-9.99%-7.84%-5.21%-5.08%-4.80%
FCF Yield
-5.96%-8.08%-6.17%-4.47%-4.21%-4.35%
Buyback Yield / Dilution
-10.31%-1.75%-16.45%-10.48%-38.77%-21.09%
SEC Filings: 10-K · 10-Q